vs
IONIS PHARMACEUTICALS INC（IONS）与WSFS FINANCIAL CORP（WSFS）财务数据对比。点击上方公司名可切换其他公司
WSFS FINANCIAL CORP的季度营收约是IONIS PHARMACEUTICALS INC的1.4倍（$275.3M vs $203.3M），WSFS FINANCIAL CORP净利率更高（31.5% vs -112.8%，领先144.3%），WSFS FINANCIAL CORP同比增速更快（7.5% vs -10.3%），过去两年IONIS PHARMACEUTICALS INC的营收复合增速更高（30.4% vs 1.7%）
IONIS制药是1989年成立的生物科技企业，总部位于美国加利福尼亚州卡尔斯巴德，专注于反义疗法、RNA干扰及CRISPR疗法的研发，2015年12月前曾以Isis制药的名称运营。
WSFS金融集团是一家金融服务企业，核心子公司WSFS银行是总部位于特拉华州及大特拉华谷地区规模最大、经营历史最久的本地管理银行与财富管理机构。集团共运营115个网点，其中88个为银行网点，分布在宾夕法尼亚、特拉华、新泽西、佛罗里达、弗吉尼亚、内华达六州，提供全面金融服务。
IONS vs WSFS — 直观对比
营收规模更大
WSFS
是对方的1.4倍
$203.3M
营收增速更快
WSFS
高出17.8%
-10.3%
净利率更高
WSFS
高出144.3%
-112.8%
两年增速更快
IONS
近两年复合增速
1.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $203.3M | $275.3M |
| 净利润 | $-229.4M | $86.8M |
| 毛利率 | 96.1% | — |
| 营业利润率 | -105.5% | — |
| 净利率 | -112.8% | 31.5% |
| 营收同比 | -10.3% | 7.5% |
| 净利润同比 | -119.8% | 31.7% |
| 每股收益（稀释后） | $-1.35 | $1.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IONSWSFS
| Q1 26 | — | $275.3M | ||
| Q4 25 | $203.3M | $271.9M | ||
| Q3 25 | $156.7M | $270.5M | ||
| Q2 25 | $452.0M | $267.5M | ||
| Q1 25 | $131.6M | $256.1M | ||
| Q4 24 | $226.6M | $261.5M | ||
| Q3 24 | $133.8M | $267.7M | ||
| Q2 24 | $225.3M | $266.0M |
净利润IONSWSFS
| Q1 26 | — | $86.8M | ||
| Q4 25 | $-229.4M | $72.7M | ||
| Q3 25 | $-128.6M | $76.4M | ||
| Q2 25 | $123.6M | $72.3M | ||
| Q1 25 | $-146.9M | $65.9M | ||
| Q4 24 | $-104.3M | $64.2M | ||
| Q3 24 | $-140.5M | $64.4M | ||
| Q2 24 | $-66.3M | $69.3M |
毛利率IONSWSFS
| Q1 26 | — | — | ||
| Q4 25 | 96.1% | — | ||
| Q3 25 | 98.5% | — | ||
| Q2 25 | 99.1% | — | ||
| Q1 25 | 98.9% | — | ||
| Q4 24 | 98.3% | — | ||
| Q3 24 | 99.2% | — | ||
| Q2 24 | 98.2% | — |
营业利润率IONSWSFS
| Q1 26 | — | — | ||
| Q4 25 | -105.5% | 35.8% | ||
| Q3 25 | -102.2% | 37.3% | ||
| Q2 25 | 30.9% | 35.7% | ||
| Q1 25 | -111.6% | 34.0% | ||
| Q4 24 | -48.9% | 32.3% | ||
| Q3 24 | -111.1% | 31.9% | ||
| Q2 24 | -29.3% | 34.0% |
净利率IONSWSFS
| Q1 26 | — | 31.5% | ||
| Q4 25 | -112.8% | 26.7% | ||
| Q3 25 | -82.1% | 28.3% | ||
| Q2 25 | 27.3% | 27.0% | ||
| Q1 25 | -111.6% | 25.7% | ||
| Q4 24 | -46.1% | 24.6% | ||
| Q3 24 | -105.0% | 24.1% | ||
| Q2 24 | -29.4% | 26.0% |
每股收益（稀释后）IONSWSFS
| Q1 26 | — | $1.64 | ||
| Q4 25 | $-1.35 | $1.33 | ||
| Q3 25 | $-0.80 | $1.37 | ||
| Q2 25 | $0.70 | $1.27 | ||
| Q1 25 | $-0.93 | $1.12 | ||
| Q4 24 | $-0.66 | $1.08 | ||
| Q3 24 | $-0.95 | $1.08 | ||
| Q2 24 | $-0.45 | $1.16 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.7B | — |
| 总债务越低越好 | $1.8B | — |
| 股东权益账面价值 | $489.1M | $2.7B |
| 总资产 | $3.5B | $22.1B |
| 负债/权益比越低杠杆越低 | 3.71× | — |
8季度趋势，按日历期对齐
现金及短期投资IONSWSFS
| Q1 26 | — | — | ||
| Q4 25 | $2.7B | $1.7B | ||
| Q3 25 | $2.2B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.1B | — | ||
| Q4 24 | $2.3B | $1.2B | ||
| Q3 24 | $2.5B | — | ||
| Q2 24 | $2.1B | — |
总债务IONSWSFS
| Q1 26 | — | — | ||
| Q4 25 | $1.8B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益IONSWSFS
| Q1 26 | — | $2.7B | ||
| Q4 25 | $489.1M | $2.7B | ||
| Q3 25 | $618.0M | $2.8B | ||
| Q2 25 | $631.7M | $2.7B | ||
| Q1 25 | $475.7M | $2.7B | ||
| Q4 24 | $588.4M | $2.6B | ||
| Q3 24 | $662.5M | $2.7B | ||
| Q2 24 | $263.7M | $2.5B |
总资产IONSWSFS
| Q1 26 | — | $22.1B | ||
| Q4 25 | $3.5B | $21.3B | ||
| Q3 25 | $3.0B | $20.8B | ||
| Q2 25 | $3.0B | $20.8B | ||
| Q1 25 | $2.8B | $20.5B | ||
| Q4 24 | $3.0B | $20.8B | ||
| Q3 24 | $3.1B | $20.9B | ||
| Q2 24 | $2.7B | $20.7B |
负债/权益比IONSWSFS
| Q1 26 | — | — | ||
| Q4 25 | 3.71× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.13× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-137.7M | — |
| 自由现金流经营现金流 - 资本支出 | $-159.0M | — |
| 自由现金流率自由现金流/营收 | -78.2% | — |
| 资本支出强度资本支出/营收 | 10.5% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-320.0M | — |
8季度趋势，按日历期对齐
经营现金流IONSWSFS
| Q1 26 | — | — | ||
| Q4 25 | $-137.7M | $220.0M | ||
| Q3 25 | $-131.4M | $121.5M | ||
| Q2 25 | $151.3M | $37.2M | ||
| Q1 25 | $-150.8M | $8.7M | ||
| Q4 24 | $-116.1M | $219.9M | ||
| Q3 24 | $-115.0M | $3.1M | ||
| Q2 24 | $-119.9M | $44.8M |
自由现金流IONSWSFS
| Q1 26 | — | — | ||
| Q4 25 | $-159.0M | $213.6M | ||
| Q3 25 | $-136.7M | $120.3M | ||
| Q2 25 | $139.0M | $35.2M | ||
| Q1 25 | $-163.4M | $6.3M | ||
| Q4 24 | $-141.6M | $205.6M | ||
| Q3 24 | $-124.0M | $-489.0K | ||
| Q2 24 | $-126.1M | $42.1M |
自由现金流率IONSWSFS
| Q1 26 | — | — | ||
| Q4 25 | -78.2% | 78.6% | ||
| Q3 25 | -87.2% | 44.5% | ||
| Q2 25 | 30.8% | 13.2% | ||
| Q1 25 | -124.1% | 2.5% | ||
| Q4 24 | -62.5% | 78.6% | ||
| Q3 24 | -92.7% | -0.2% | ||
| Q2 24 | -56.0% | 15.8% |
资本支出强度IONSWSFS
| Q1 26 | — | — | ||
| Q4 25 | 10.5% | 2.3% | ||
| Q3 25 | 3.4% | 0.5% | ||
| Q2 25 | 2.7% | 0.7% | ||
| Q1 25 | 9.6% | 0.9% | ||
| Q4 24 | 11.3% | 5.5% | ||
| Q3 24 | 6.8% | 1.4% | ||
| Q2 24 | 2.8% | 1.0% |
现金转化率IONSWSFS
| Q1 26 | — | — | ||
| Q4 25 | — | 3.03× | ||
| Q3 25 | — | 1.59× | ||
| Q2 25 | 1.22× | 0.51× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 3.43× | ||
| Q3 24 | — | 0.05× | ||
| Q2 24 | — | 0.65× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IONS
| Products | $58.0M | 29% |
| Spinraza Royalties | $54.0M | 27% |
| Collaborative Agreement Revenue | $52.4M | 26% |
| Wainus Royalties | $16.0M | 8% |
| Wainua Joint Development Revenue | $9.6M | 5% |
| Other Commercial | $7.6M | 4% |
| Other Royalties | $5.7M | 3% |
WSFS
暂无分部数据
